NCT06383871View on ClinicalTrials.gov

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

PHASE1RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Advanced Malignant Tumour
Interventions
DRUG

HRS-7058 capsule/ HRS-7058 tablet

HRS-7058 capsule/ HRS-7058 tablet

Trial Locations (1)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY